Breaking News
SPLC 'Fascism Expert' Funneled $1.2 MILLION in Donor Cash to Her Neo-Nazi Informant/Lover
Israeli Ministers Say Israel Isn't Bound by US-Iran Deal, Won't Withdraw From Lebanon
EXCLUSIVE: Top FBI Whistleblower Says The Supposed Terror Plot Targeting The White House...
Heterofatalism
Top Tech News
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
How EMF's cause disease
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap
5-in-1 miniature surgical robot is the size of a seed 
Samumed worth $12 billion is working on tissue regeneration to combat alzheimers and more
They have a biotechnology platform based on small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
One of the primary signaling pathways that regulate the self-renewal and differentiation of adult stem cells is the Wnt pathway, which plays a crucial role in tissue health, ranging from formation to replenishment and from repair to regeneration of various tissues.
Samumed's small-molecule drug platform is harnessing the innate restorative power of the Wnt pathway to reverse the course of severe and prevalent diseases.